Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

Lancet Commends U.K. All-Parliamentary Group on AIDS Call For HIV Drug Patent Pool

From Henry J. Kaiser Family Foundation

July 24, 2009

A Lancet editorial examines recent recommendations by the U.K. All-Parliamentary Group on AIDS for pharmaceutical companies to implement an HIV drug patent pool -- an appeal, "Drug companies have dismissed" in the past. The authors conclude, "Although the voice of the All-Parliamentary Group is a welcome addition to the fight for improved access to essential medicines, unless there is political clout behind the rhetoric, drug companies will continue to resist potential solutions, such as patent pools" (7/25).

Back to other news for July 2009


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report.
 
See Also
More on HIV Drug Patent Policies

 

Advertisement